{"version":"1.0","provider_name":"Mauna Kea Technologies","provider_url":"https:\/\/www.maunakeatech.com\/fr\/","title":"Le journal des biotechs : Sacha Loiseau - Mauna Kea Technologies","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"BaOQL7uKrX\"><a href=\"https:\/\/www.maunakeatech.com\/fr\/non-classifiee\/le-journal-des-biotechs-sacha-loiseau-2\/\">Le journal des biotechs : Sacha Loiseau<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.maunakeatech.com\/fr\/non-classifiee\/le-journal-des-biotechs-sacha-loiseau-2\/embed\/#?secret=BaOQL7uKrX\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0Le journal des biotechs : Sacha Loiseau\u00a0\u00bb &#8212; Mauna Kea Technologies\" data-secret=\"BaOQL7uKrX\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.maunakeatech.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/dca1eec959e4c129a01665c29b9efd0b63bd3b74-1024x551.png","thumbnail_width":1024,"thumbnail_height":551,"description":"Ce num&eacute;ro du Journal des biotechs est fourni. Dans le point d&#39;actualit&eacute;, on revient avec Fr&eacute;d&eacute;ric Gomez, analystes chez Pharmium Securities sur les dossiers du moment : Innate Pharma, Nanobiotix, Pixium et Carmat. Au programme &eacute;galement, non pas un mais deux entretien. Le premier avec Sacha Loiseau. Le PDG de Mauna Kea revient sur les [&hellip;]"}